Hinge Health, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Teddie Benjamin Wardi, a Director of Hinge Health, Inc., reported a transaction in 4,637 shares of common stock on August 10, 2026.
NYSE
Gabriel M.I. Mecklenburg, a Director of Hinge Health, Inc., reported multiple transactions in common stock on August 4, 2026.
NYSE
James Pursley, President of Hinge Health, Inc., reported a transaction in 831 shares of common stock on August 1, 2026.
NYSE
James Budge, Chief Financial Officer of Hinge Health, Inc., reported a transaction in 4,614 shares of common stock on August 1, 2026.
NYSE
Gabriel M.I. Mecklenburg, a Director of Hinge Health, Inc., received 944,250 shares of common stock on July 27, 2026.
NYSE
Daniel Antonio Perez, CEO & Co-Founder, a Director and 10% owner of Hinge Health, Inc., reported multiple transactions in common stock on July 27, 2026.
NYSE
Insight Holdings Group, LLC and affiliated entities reported significant transactions involving Hinge Health, Inc. (HNGE) Class A Common Stock, including conversions and sales.
NYSE
Hinge Health Director Tyler Sloat acquired 246 shares of Class A Common Stock through the settlement of vested RSUs on July 5, 2026.
NYSE
Hinge Health, Inc. Chief Financial Officer, James Budge, reported a transaction involving Class A Common Stock on July 1, 2026.
NYSE
Hinge Health's Exec. Chairman & Co-Founder, Gabriel Mecklenburg, reported transactions involving Class A Common Stock, including acquisitions and dispositions under a Rule 10b5-1 trading plan.
NYSE
Insight Holdings Group, LLC reported significant transactions involving Hinge Health, Inc. Class A Common Stock, including both acquisitions and dispositions.
NYSE
Insight Holdings Group, LLC, a significant stakeholder, reported a series of transactions involving Class A Common Stock of Hinge Health, Inc. on June 25, 2026.
NYSE
Insight Holdings Group, LLC reported transactions involving Hinge Health, Inc. (HNGE) Class A Common Stock on June 24, 2026.
NYSE
Insight Holdings Group, LLC reported significant transactions involving Hinge Health, Inc. Class A Common Stock, including conversions and sales, on June 22-24, 2026.
NYSE
Insight Holdings Group, LLC and affiliated entities reported transactions involving Hinge Health, Inc. Class A and Class B common stock on June 16, 2026.
NYSE
Director Elliott Robinson reports the sale of Hinge Health Class A Common Stock by Bessemer Venture Partners funds.
NYSE
Executive Chairman Gabriel Mecklenburg executed a pre-planned sale of 50,000 shares of Hinge Health Class A Common Stock.
NYSE
Director Kristina M. Leslie acquired 3,837 restricted stock units as part of Hinge Health's non-employee director compensation program.
NYSE
Director Elliott Robinson reports the sale of Hinge Health Class A Common Stock by Bessemer Venture Partners funds.
NYSE
Hinge Health's Exec. Chairman & Co-Founder, Gabriel Mecklenburg, reported the sale of Class A Common Stock valued between $55.21 and $62.07 per share, executed under a pre-arranged Rule 10b5-1 trading plan.
NYSE
CFO James Budge disposed of 9,986 shares of Hinge Health Class A Common Stock to satisfy tax withholding obligations.
NYSE
Hinge Health President James Pursley disposed of 6,326 shares of Class A Common Stock to cover tax withholding obligations.
NYSE
Hinge Health CFO James Budge sold 5,907 shares of Class A Common Stock on May 26, 2026, pursuant to a Rule 10b5-1 trading plan.
NYSE
Hinge Health President James Pursley sold 16,000 shares of Class A Common Stock via a pre-arranged 10b5-1 trading plan.
NYSE
Hinge Health Executive Chairman and Co-Founder Gabriel Mecklenburg sold 83,333 shares of Class A Common Stock via a Rule 10b5-1 trading plan.
NYSE
Hinge Health's Chief Financial Officer, James Budge, reported a sale of Class A Common Stock executed under a pre-arranged trading plan.
NYSE
Hinge Health President James Pursley acquired 65,000 restricted stock units as part of an exempt company award.
NYSE
Hinge Health CFO James Budge was granted 65,000 restricted stock units as part of an exempt equity award.
NYSE
Hinge Health, Inc. CFO James Budge reported the sale of Class A Common Stock under a pre-arranged trading plan.
NYSE
Director Elliott Robinson reports the sale of Hinge Health Class A Common Stock by Bessemer Venture Partners funds.